SOP 201 - Composition of the REB

Research Ethics at ³ÉÈË´óƬ Standard Operating Procedure

Title: Composition of the REB

SOP Code: 201.004

Effective Date: 05/15/2023

Site Approvals:

NAME TITLE DATE (MM/DD/YYYY)
Meera Sidhu Research Ethics Manager 12/01/2023
Steven Smith Deputy Vice-Principal Research 12/04/2023
Jacob Brower Chair GREB 05/08/2024
Dean Tripp Chair HSREB 05/07/2024

 

1.0 PURPOSE

This standard operating procedure (SOP) describes the Research Ethics Board (REB) membership composition requirements.

2.0 SCOPE

This SOP pertains to REBs that review human participant research in compliance with applicable regulations and guidelines.

3.0 RESPONSIBILITIES

All REB members and REB Office Personnel are responsible for ensuring that the requirements of this SOP are met.

The REB Chair or designee is responsible for ensuring that the composition of the REB meets the applicable regulatory requirements.

4.0 DEFINITIONS

See Glossary of Terms.

5.0 PROCEDURE

Individual members of an REB must be qualified through training, experience, and expertise to ascertain the acceptability of proposed research in terms of ethical principles and applicable regulations, guidelines, and standards about human participant protection.

To promote a complete and adequate review of the type of research commonly reviewed by the REB, the REB must include appropriate diversity; therefore, the selection of members must consider professional expertise (including both scientific and non-scientific) to assess the research submitted for review.

Important considerations are also race, sex, cultural backgrounds, clinical and research experience, organizational affiliation, and sensitivity to such issues as broad representation from organizations served by the REB.

5.1    Selection of REB Members

5.1.1    In selecting REB members, equal consideration shall be given to qualified persons of both sexes. No appointment shall be made solely based on sex.

5.1.2    The REB will make every effort to include cultural and ethnic minorities to represent the population from which research participants are recruited within the scope of available expertise needed to conduct its functions.

5.1.3    The REB membership will not consist entirely of members of one profession.

5.1.4    REB members will be selected based on the needs of the REB as outlined below and per applicable regulations, guidelines, and standards.

5.2    Composition of the REB

5.2.1    The membership of the REB will comply with the Food and Drugs Act and applicable Regulations, the Tri-Council Policy Statement; Ethical Conduct for Research Involving Humans, the International Council on Harmonisation Good Clinical Practice Guidelines, and the US Code of Federal Regulations.

5.2.2    The REB Chair or designee monitors the REB membership composition for appropriate membership in relation to the nature and volume of research submissions.

5.2.3    The REB will include at least five members represented by the following categories:

  • At least two members who have expertise in relevant research disciplines fields and methodologies covered by the REB (for biomedical clinical trials, this will include at least one member who practices medicine or dentistry and who is in good standing with their regulatory body),
  • At least one member who is primarily experienced in non-scientific disciplines
  • At least one member who is knowledgeable in ethics,
  • At least one member who is knowledgeable in the relevant law. This is mandatory for biomedical research and is advisable, but not required, for other areas of research and
  • At least one community member who has no affiliation with the organization or the sponsor and is not part of the immediate family of a person affiliated with the organization.

5.2.4    A member may fulfill up to two representative capacities or disciplines.

5.2.5    Members will include men and women, a majority of whom are Canadian citizens or permanent residents, and who collectively have the qualifications and experience to review and evaluate the proposed research's science, medical aspects and ethics.

5.2.6    Membership, when required, should include at least one member with expertise in complementary or alternative care or pediatric health research.

5.2.7    Membership, when regularly required, for the review of research on topics related to Indigenous peoples or affecting Indigenous communities should include a member with relevant and competent knowledge and expertise in Indigenous cultures or the inclusion of an ad hoc advisor for occasional review.

5.2.8    Additional membership as required by applicable legislation or guidelines.

5.3    Alternate Members

5.3.1    The REB Chair or designee may ask an alternate REB member to attend an REB meeting to draw on their expertise in an area relevant to that meeting’s deliberations or establish a quorum for that meeting in the absence of the regular REB member.
 
5.3.2    Only alternate REB members of comparable qualifications may substitute for an REB member (a non-scientific member may not substitute for a scientific member);

5.3.3    The minutes shall document when an alternate REB member replaces a primary REB member.

5.4    REB Chair

5.4.1    Whenever possible and practicable, the REB Chair will be selected from experienced REB members who have expressed interest in becoming the REB Chair and are familiar with the applicable regulations and guidance documents.

5.4.2    If applicable, the REB Office Personnel updates the REB membership roster and OHRP registration to reflect this change.

5.5    Ad Hoc Advisors/Affiliate Members

5.5.1    At their discretion, the REB Chair or designee may invite individuals with expertise and competence in particular areas to assist in the review of issues that require expertise beyond or in addition to that available on the REB.

5.5.2    The ad hoc advisor or affiliate member may be asked to participate in the REB meeting to lend their expertise to the discussions.

5.5.3    All ad hoc advisors or affiliate member shall sign a Confidentiality of Information and Conflict of Interest Agreement.

5.5.4    The ad hoc advisor or affiliate member may not contribute directly to the REB’s decision, and their presence or absence shall not be used in establishing a quorum.

5.5.5    Documentation of key information provided by the ad hoc advisor or affiliate member shall be summarized in the REB minutes and if available, the written report shall be placed in the REB files.

5.6    Observers at REB Meetings

5.6.1    The REB may allow observers to attend its meetings.
 
5.6.2    Observers will sign a Confidentiality of Information and Conflict of Interest Agreement agreeing to abide by the REB conflict of interest and confidentiality policies.

5.6.3    Where the REB finds that an observer qualifies as an expert in relation to the research under consideration, the observer may be allowed to contribute input if it is relevant and significant to the discussion.

5.6.4    Observers shall not participate when the REB discusses its decision, reaches a consensus or votes on the application.

5.6.5    The minutes will reflect any observers' presence, expertise, and contributions, when applicable.

6.0 REFERENCES

See References.

SOP Code Effective Date Summary of Changes
SOP201.001 09/15/2014 Original version
SOP201.002 03/08/2016 No revisions needed
SOP201.003 10/08/2019

5.2.1: ICH ‘Conference’ changed to ‘Council’; Removed “Research ethics oversight of biomedical clinical trials (CAN/CGSB-191.1-2013)
5.2.7: change in language and requirements for addressing research involving the Indigenous
community. Removal of: ‘At least one member, when possible, who is from an identifiable Aboriginal community or Native centre, when the REB reviews research that recruits participants from that community’; New Language:
‘Membership, when regularly required, for the review of research on topics related to Indigenous peoples or affecting Indigenous communities, should include a member with relevant and
competent knowledge and expertise in Indigenous cultures, or the inclusion of an ad hoc advisor for occasional review.’

SOP201.004 05/15/2023 Changed his/her to their